CSF2 and Sepsis: Strategies to stimulate this immunoparalysis phase of sepsis as IFN-γ and granulocyte-macrophage colony-stimulating factor (GM-CSF) have been developed in animals, but extensive clinical studies are needed to test their safety and efficacy [86].